XML 35 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMON STOCK AND STOCK PLANS (Details 2) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 29, 2013
item
Dec. 30, 2012
Dec. 25, 2011
Dec. 29, 2013
Stock options and SARs
Dec. 30, 2012
Stock options and SARs
Dec. 25, 2011
Stock options and SARs
Dec. 29, 2013
Stock appreciation rights (SARs)
Dec. 29, 2013
RSUs
Dec. 30, 2012
RSUs
Dec. 25, 2011
RSUs
Dec. 29, 2013
RSUs
Minimum
Dec. 29, 2013
RSUs
Maximum
Dec. 29, 2013
Employee Plans
Dec. 29, 2013
Employee Plans
Maximum
Dec. 29, 2013
Employee Plans
Class A Common Stock
item
Dec. 29, 2013
2001 Director Plan
Dec. 29, 2013
2012 Plan
Stock options and SARs
Maximum
May 31, 2012
2012 Plan
Class A Common Stock
Dec. 29, 2013
2012 Plan
Class A Common Stock
Non-employee director
Dec. 30, 2012
2012 Plan
Class A Common Stock
Non-employee director
Dec. 29, 2013
2004 Plan
Class A Common Stock
Dec. 29, 2013
Purchase Plan
Class A Common Stock
Dec. 30, 2012
Purchase Plan
Class A Common Stock
Stock-based compensation plans                                              
Number of stock-based compensation plans 5                           2                
Shares reserved for issuance to employees                                         9,000,000   4,625,000
Purchase price expressed as a percentage of fair market value of common stock                                           85.00%  
Vesting period             4 years       2 years 3 years 4 years                    
Outstanding grants (in shares)                         0     9,000   5,000,000          
Terms of award                           10 years     10 years            
Granted (in shares)               483,150 1,082,000 740,000                 15,000 15,000      
Issuance of shares under the plan                                     165,000 150,000      
RSU's                                              
Nonvested at the beginning of the period (in shares)               1,102,000 1,445,000 845,000                          
Granted (in shares)               483,150 1,082,000 740,000                 15,000 15,000      
Vested (in shares)               (320,000) (765,000)                            
Forfeited (in shares)               (33,500) (660,000) (140,000)                          
Nonvested at the end of the period (in shares)               1,231,650 1,102,000 1,445,000                          
Weighted Average Grant Date Fair Value                                              
Outstanding at the beginning of the period (in dollars per share)               $ 2.98 $ 3.73 $ 3.42                          
Granted (in dollars per share)               $ 2.46 $ 2.59 $ 4.08                          
Vested (in dollars per share)               $ 4.08 $ 3.42                            
Forfeited (in dollars per share)               $ 2.48 $ 3.48 $ 3.70                          
Outstanding at the end of the period (in dollars per share)               $ 2.50 $ 2.98 $ 3.73                          
Additional disclosures                                              
Total fair value               $ 800,000                              
Unrecognized compensation costs                                              
Unrecognized compensation costs for non-vested RSUs (in dollars)               1,400,000                              
Unrecognized compensation costs for non-vested options & SARs (in dollars)       2,000,000                                      
Weighted average period for unrecognized compensation cost expected to be recognized       2 years 3 months 18 days       1 year 9 months 18 days                              
Options/SARs                                              
Outstanding at the beginning of the period (in shares) 6,194,500 6,723,250 6,632,200                                        
Granted (in shares) 775,000 1,017,500 1,078,500                                        
Exercised (in shares) (545,750) (27,250) (152,750)                                        
Forfeited (in shares) (58,500) (1,217,750) (132,250)                                        
Expired (in shares) (254,750) (301,250) (702,450)                                        
Outstanding at the end of the period (in shares) 6,110,500 6,194,500 6,723,250                                        
Vested and Expected to Vest at the end of the period (in shares) 5,955,143                                            
Options exercisable (in shares) 3,983,875 3,826,250 4,082,500                                        
Weighted Average Exercise Price                                              
Outstanding at the beginning of the period (in dollars per share) $ 11.45 $ 22.01 $ 26.82                                        
Granted (in dollars per share) $ 2.46 $ 2.76 $ 4.08 $ 2.46 $ 2.76 $ 4.08                                  
Exercised (in dollars per share) $ 1.72 $ 1.70 $ 1.73                                        
Forfeited (in dollars per share) $ 3.30 $ 54.52 $ 3.99                                        
Expired (in dollars per share) $ 48.97 $ 48.33 $ 47.86                                        
Outstanding at the end of the period (in dollars per share) $ 9.69 $ 11.45 $ 22.01                                        
Vested and Expected to Vest at the end of the period (in dollars per share) $ 9.87                                            
Aggregate Intrinsic Value                                              
Outstanding at the beginning of the period (in dollars) 1,846,000 874,000 6,060,000                                        
Exercised (in dollars) 847,000 33,000 382,000                                        
Outstanding at the end of the period (in dollars) 2,384,000 1,846,000 874,000                                        
Vested and Expected to Vest at the end of the period (in dollars) 2,281,000                                            
Options exercisable (in dollars) $ 1,306,000 $ 1,335,000 $ 397,000